Next Article in Journal
Ubiquitin-Like Modifiers: Emerging Regulators of Protozoan Parasites
Next Article in Special Issue
Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis
Previous Article in Journal
The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation
Previous Article in Special Issue
Regulation of Signaling and Metabolism by Lipin-mediated Phosphatidic Acid Phosphohydrolase Activity

cPLA2α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation

Department of Biology, Norwegian University of Science and Technology, Realfagbygget, 7491 Trondheim, Norway
Center for Oral Health Services and Research (TkMidt), 7030 Trondheim, Norway
Author to whom correspondence should be addressed.
Biomolecules 2020, 10(10), 1402;
Received: 7 September 2020 / Revised: 25 September 2020 / Accepted: 29 September 2020 / Published: 2 October 2020
(This article belongs to the Special Issue Phospholipases: From Structure to Biological Function)
As a regulator of cellular inflammation and proliferation, cytosolic phospholipase A2 α (cPLA2α) is a promising therapeutic target for psoriasis; indeed, the cPLA2α inhibitor AVX001 has shown efficacy against plaque psoriasis in a phase I/IIa clinical trial. To improve our understanding of the anti-psoriatic properties of AVX001, we sought to determine how the compound modulates inflammation and keratinocyte hyperproliferation, key characteristics of the psoriatic epidermis. We measured eicosanoid release from human peripheral blood mononuclear cells (PBMC) and immortalized keratinocytes (HaCaT) and studied proliferation in HaCaT grown as monolayers and stratified cultures. We demonstrated that inhibition of cPLA2α using AVX001 produced a balanced reduction of prostaglandins and leukotrienes; significantly limited prostaglandin E2 (PGE2) release from both PBMC and HaCaT in response to pro-inflammatory stimuli; attenuated growth factor-induced arachidonic acid and PGE2 release from HaCaT; and inhibited keratinocyte proliferation in the absence and presence of exogenous growth factors, as well as in stratified cultures. These data suggest that the anti-psoriatic properties of AVX001 could result from a combination of anti-inflammatory and anti-proliferative effects, probably due to reduced local eicosanoid availability. View Full-Text
Keywords: cPLA2α; psoriasis; proliferation; anti-inflammatory cPLA2α; psoriasis; proliferation; anti-inflammatory
Show Figures

Figure 1

MDPI and ACS Style

Ashcroft, F.J.; Mahammad, N.; Midtun Flatekvål, H.; J. Feuerherm, A.; Johansen, B. cPLA2α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation. Biomolecules 2020, 10, 1402.

AMA Style

Ashcroft FJ, Mahammad N, Midtun Flatekvål H, J. Feuerherm A, Johansen B. cPLA2α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation. Biomolecules. 2020; 10(10):1402.

Chicago/Turabian Style

Ashcroft, Felicity J., Nur Mahammad, Helene Midtun Flatekvål, Astrid J. Feuerherm, and Berit Johansen. 2020. "cPLA2α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation" Biomolecules 10, no. 10: 1402.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop